ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,887,364 | +17.0% | 1,474,879 | +5.1% | 0.00% | – |
| Q2 2023 | $14,432,781 | +36.5% | 1,403,967 | +2.5% | 0.00% | – |
| Q1 2023 | $10,574,154 | +5.7% | 1,369,709 | +0.7% | 0.00% | – |
| Q4 2022 | $9,999,697 | +23.7% | 1,360,503 | +21.2% | 0.00% | – |
| Q3 2022 | $8,084,000 | +50.8% | 1,122,800 | +78.3% | 0.00% | – |
| Q2 2022 | $5,359,000 | -15.6% | 629,773 | -11.0% | 0.00% | – |
| Q1 2022 | $6,347,000 | -34.3% | 707,598 | +1.4% | 0.00% | – |
| Q4 2021 | $9,664,000 | +56.0% | 697,754 | +20.2% | 0.00% | – |
| Q3 2021 | $6,194,000 | +19.7% | 580,478 | +0.9% | 0.00% | – |
| Q2 2021 | $5,176,000 | -15.1% | 575,217 | -0.0% | 0.00% | – |
| Q1 2021 | $6,099,000 | -11.6% | 575,343 | +5.1% | 0.00% | – |
| Q4 2020 | $6,900,000 | +147.8% | 547,643 | +72.8% | 0.00% | – |
| Q3 2020 | $2,785,000 | +53.4% | 316,891 | +69.4% | 0.00% | – |
| Q2 2020 | $1,816,000 | +237.5% | 187,043 | 0.0% | 0.00% | – |
| Q1 2020 | $538,000 | -25.1% | 187,043 | 0.0% | 0.00% | – |
| Q4 2019 | $718,000 | -2.0% | 187,043 | 0.0% | 0.00% | – |
| Q3 2019 | $733,000 | -14.1% | 187,043 | -7.7% | 0.00% | – |
| Q2 2019 | $853,000 | +2.9% | 202,582 | +67.7% | 0.00% | – |
| Q1 2019 | $829,000 | +88.0% | 120,782 | +0.8% | 0.00% | – |
| Q4 2018 | $441,000 | -69.4% | 119,782 | -47.4% | 0.00% | – |
| Q3 2018 | $1,442,000 | -12.1% | 227,834 | +5.2% | 0.00% | – |
| Q2 2018 | $1,640,000 | -7.7% | 216,634 | -2.4% | 0.00% | – |
| Q1 2018 | $1,776,000 | -18.6% | 222,021 | +14.0% | 0.00% | – |
| Q4 2017 | $2,182,000 | +23.5% | 194,831 | +27.9% | 0.00% | – |
| Q3 2017 | $1,767,000 | – | 152,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 6,708,288 | $76,809,898 | 25.63% |
| Lynx1 Capital Management LP | 2,404,614 | $27,532,830 | 18.21% |
| GREAT POINT PARTNERS LLC | 3,078,633 | $35,250,348 | 6.42% |
| Ghost Tree Capital, LLC | 664,132 | $7,604,311 | 2.50% |
| Frazier Life Sciences Management, L.P. | 2,985,757 | $34,186,918 | 2.27% |
| Paradigm Biocapital Advisors LP | 2,421,743 | $27,728,957 | 1.88% |
| COMMODORE CAPITAL LP | 1,325,000 | $15,171,250 | 1.77% |
| Nan Fung Group Holdings Ltd | 182,280 | $2,087,106 | 1.69% |
| Omega Fund Management, LLC | 153,700 | $1,759,865 | 1.62% |
| Octagon Capital Advisors LP | 750,000 | $8,587,500 | 1.32% |